Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_06-cv-01063/USCOURTS-caed-2_06-cv-01063-2/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1441 Petition for Removal- Product Liability

---

ORDER GRANTING GSK’S EX PARTE APPLICATION TO FILE CERTAIN PAGES OF ITS EXPERT’S REPORT UNDER SEAL

- 1 - 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

SACRAMENTO DIVISION 

TERRI S. O’NEAL, individually and as successorin-interest to the Estate of BENJAMIN L. BRATT; 

BARRY M. BRATT, individually, 

 Plaintiffs, 

 vs. 

SMITHKLINE BEECHAM CORPORATION d/b/a 

GLAXOSMITHKLINE, a Pennsylvania 

Corporation; and DOES 1-50. 

 Defendants. 

Case No.: 2:06-cv-01063-FCD-DAD 

ORDER GRANTING 

DEFENDANT SMITHKLINE 

BEECHAM CORPORATION d/b/a 

GLAXOSMITHKLINE’s EX PARTE 

APPLICATION TO FILE CERTAIN 

PAGES OF DR. SCHLESSELMAN’S 

EXPERT REPORT UNDER SEAL 

 The Court finds good cause to seal certain pages of Defendant SmithKline Beecham Corporation 

d/b/a GlaxoSmithKline’s (“GSK”) Retained Supplemental Expert’s Report, which contains sensitive, 

confidential, proprietary information, confidential research, and trade secrets regarding Paxil. 

Accordingly, the Court orders that pages 5 through 11, 15 through 22, and 28 through 31 of Dr. James 

Schessleman’s expert report shall be SEALED. 

 

 IT IS SO ORDERED. 

DATED: July 18, 2007 

Case 2:06-cv-01063-FCD-DAD Document 54 Filed 07/19/07 Page 1 of 1